Trial Number

376-23

Participant Age Range

6 years to 17 years

Participant Gender

Any

Enrolling Participants

Yes

Overview

“Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1”

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

Provider

Jasmin M Dao, MD
Neurology - Pediatric, Pediatric Neurology
View Profile
Jasmin M Dao, MD
Neurology - Pediatric, Pediatric Neurology
View Profile

Location

Main Campus
2801 Atlantic Ave.
Long Beach
(562) 933-5437
Location Details
Main Campus
2801 Atlantic Ave.
Long Beach
(562) 933-5437
Location Details

Related Topics

Main Campus
Name
Address
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
Are you a current Miller Children's patient?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.